STEP BY STEP
Biointelect is with you every step of the way, providing the deep expertise to ensure your life science innovation is ready for successful commercialisation.
Navigate the challenges of bringing a therapy to market leveraging our broad cross-functional experience. Build vital knowledge to inform all stages of market readiness.
Discover Our Services
At Biointelect, we ensure you navigate the right path to market for new health technologies by providing industry-leading commercialisation consulting at each stage of the development pathway.
Our services extend from product development strategy, clinical affairs and director services, commercialisation and regulatory strategy, to market access pathways and government and health policy.
A Proven Track Record
Our approach ensures a trusted partnership to complement the capabilities of your team. Consulting across the entire life science ecosystem, Biointelect is uniquely positioned to provide clients with expert guidance, and agile fit for purpose approach, including identifying potential future challenges and meeting evolving sector requirements.
Biointelect have proudly worked with a diverse network of client innovators including early-stage biotech and medtech companies, pharmaceutical companies, universities, research institutes, government, and other not-for-profit organisations both in Australia and around the globe.
Horizon scanning is a process or system which seeks to systematically and proactively identify current, new, and emerging health technologies...
Macquarie Park Innovation District (MPID) is Australia’s first innovation district, home to the world class Macquarie University, headquarters of multi-national...
Resources
Discover the latest resources, news, white papers and policy position papers from the life science sector through the global lens of our Biointelect experts.
There is an identified need in Australia’s Vaccine Value Chain to boost vaccine development, translation, commercialisation and access. Globally, there...
Horizon scanning is a process or system which seeks to systematically and proactively identify current, new, and emerging health technologies...
Macquarie Park Innovation District (MPID) is Australia’s first innovation district, home to the world class Macquarie University, headquarters of multi-national...
Driving more efficient and accelerated results from pre-clinical trials to commercialisation of new therapies for Australian, European and U.S. firms....
With the rapid and ongoing global growth of cell and gene (C&G) products, there is an opportunity for Australia to...
The current healthcare environment in Australia offers various opportunities for stakeholders, including patients, to engage with the health system and...
Get in Touch
Wherever you are in your new product journey, Biointelect’s unique expertise across each stage of the life science value chain means we are ready to bring your innovative life science to market.
Take the next steps in advancing healthcare for all by contacting our team of local Australian and global life science experts today.
